Author

Jean‐Luc Van Laethem

Erasmus HospitalORCID 0000-0002-0785-0580Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Anaïs Boisson· 1 shared Christelle BouchartiD· 1 shared Dirk Van GesteliD· 1 shared Eric QuertinmontiD· 1 shared Ilse RoomaniD· 1 shared Jean‐Baptiste BachetiD· 1 shared Julie NaveziD· 1 shared Karen E Willard-GalloiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anaïs Boisson

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Stereotactic Body Radiotherapy

Christelle Bouchart, Oier Azurmendi Senar, Julie Navez, Laurine Verset, Anaïs Boisson, Matthieu Hein, Kosta Stosic, Eric Quertinmont, Vjola Tafciu, Shulin Zhao, Léo Mas, Nicky D’Haene, Dirk Van Gestel, Luigi Moretti, Ilse Rooman, , Jean‐Luc Van Laethem

This study shows that combining FOLFIRINOX with stereotactic body radiotherapy remodels pancreatic ductal adenocarcinoma, improving stromal and metabolic features and prognosis.

bioRxiv · Apr 30, 2024 · PreprintCancer Biology